New Refrshing 2 in 1 Roll on Inhaler for Headache Blocked Nose

Name: New Refrshing 2 in 1 Roll on Inhaler for Headache Blocked Nose
Brand: Shandong Vianor Pharma Co., Ltd.
SKU: 2110190502

Shandong, ChinaShandong Vianor Pharma Co., Ltd.

US$0.15-0.50

30,000 Pieces

Sample price:US$10.00/piece.Request sample

Product profile

Customization

Available

Cold Hot Dressing Application

Psoatic Strain, Sciatica, Cervical Spondylitis, Rheumatism, Arthritis, Sprain, Muscle Strain

Usage Mode

For External Use

Model NO.

VIA-250803032

Nature

Yes

Customized

Type

Massage

Group

Adults

Certification

CE, FDA, MSDS, GMP, GMPC ISO

Brand Name

Vianor/OEM

Function

Car Sick, Refreshing, Mosquito Bite, Headache, Nasal

Application

Head, Wrist, Any Skin Part

Shelf Life

3 Years

Quality Certification

Instrument Classification

Class I

Color

Customerized Color

Package

Metal Tin or Glass Bottle

Feature

Cream with Mint Smell

OEM

Availabe

Sample

Availalbe

Selling Units

Single Item

Safety Standard

CE/FDA

Size

2g.10g, 20g, 25g

Prouduct Function

Relieve Pain, Headache, Car Sickness, Mosquito Bite

Transport Package

Carton

Specification

960pcs/ctn 480pcs/ctn, 240pcs/ctn

Trademark

OEM, ODM

Origin

China

Production Capacity

20000PCS/Day

Company profile

High Repeat Buyers ChoiceODM ServicesOEM ServicesQuality Assurance

Shandong Vianor Pharma Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from SamplesExport Year: 2014-05-01Nearest Port: Qingdao Port, Shanghai PortAverage Response Time: ≤2.63h

AI-Powered supplier vetting

SummaryThe supplier is a combined company and a professional technical supplier focused on medical hygiene materials, dressings, physical therapy and rehabilitation equipment, disinfection products, medical devices, adhesive products, and related technical services. It has an SDK, sample-based customization, raw-material traceability, four quality inspectors, and documented corrective/preventive action procedures. Export sales account for 90%, and the supplier has five years of export experience. However, it does not provide 3D software design, launched no new products in the past year, lacks an effective manufacturing-capacity contract with related subcontractors, and has no overseas warehouse or showroom. Financial records are indicated for 2022–2024, but no financial results are provided. Customer cases and specific certifications are not sufficiently documented.

Supplier typeThe supplier identifies as a professional technical supplier and a combined company. Its stated scope covers production and sales of Class II medical hygiene materials and dressings, Class II physical therapy and rehabilitation equipment, disinfection products, Class I medical devices, and related technical consultation and sales activities.

R&D capabilityThe supplier has R&D capability as a professional technical supplier and an available SDK, but it does not provide 3D software design services and launched no new products during the past year. Its demonstrated capability is therefore stronger in technical support and sample-based development than in recent product innovation.

Production capacityThe supplier has a defined and uniformly followed finished-product inspection instruction, four quality assurance and quality-control inspectors, raw-material traceability, in-stock capacity, and one-month stated lead times. Nevertheless, it has no valid manufacturing-capacity contract with its factory and related subcontractors, which is a documented production-management deficiency.

Customization capabilityThe supplier provides customization from samples and has an available SDK, indicating capability to adapt products or support technical integration. No 3D software design service is provided, so customization is supported but not comprehensive across design formats.